Delivery Order SPE2DB20D2104-SPE2DB25FMWUT
- Not listed
- The Defense Logistics Agency awarded a $1,636.68 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for MIEBO 100% eye drop (3ml), with performance completed by July 28, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,654.20 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop 3ML, a pharmaceutical product for ophthalmic use. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with an ultimate completion date of July 22, 2025, just one day after the award date of July 21, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is...
- The Defense Logistics Agency awarded a delivery order valued at $2,072.18 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a small-value delivery order under the company's larger pharmaceutical supply vehicle with DLA. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,723.79 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $24,495 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop product (3ML units) on July 25, 2025, with completion scheduled for July 28, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical supplier to...
- The Defense Logistics Agency awarded a $8,694.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of MIEBO 100% Eye Drop in 3ML units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for ultimate completion on July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,795.08 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml units) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,949.40 to AmerisourceBergen Drug Corp for supply of Miebo 100% eye drops (3mL) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $5,614.89 to AmerisourceBergen Drug Corp for MIEBO 100% eye drops (3 mL) on July 21, 2025, with completion scheduled for July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This...
- The Defense Logistics Agency awarded a $9,558.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drops (3mL) on July 25, 2025, with a completion date of July 28, 2025. This non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child contract under a larger vehicle supporting federal...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWUTDelivery Order
The Defense Logistics Agency awarded a $1,448.13 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop (3ML) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical commodities to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and Defense Health Agency. The company's extensive portfolio of federal contracts demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for ophthalmic medication reflects the company's ongoing role in supplying essential pharmaceuticals to military and veteran healthcare systems through competitive federal procurement channels.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/29/25 |